AI medical-device validation
How to Compare AI Medical-Device Validation Evidence
Compare validation studies in FDA AI medical-device summaries without mixing analysis units, tasks, populations, endpoints, or study designs.
Direct answer
Compare AI medical-device evidence study by study: intended task, study design, data source, sites, population, analysis unit, reference standard, endpoint, sample size, and reported performance. Do not rank devices by a pooled headline metric when the underlying tasks or denominators differ.
Compare source-quoted validation evidence →Normalize the study before comparing the number
A sensitivity, specificity, AUC, agreement score, or error measure is interpretable only with its task and analysis unit. Per-lesion, per-image, per-study, and per-patient results are not interchangeable.
Create a comparison row for each disclosed validation study rather than one row per device. That keeps standalone testing separate from reader-assist testing and prevents retrospective and prospective designs from being collapsed into a single score.
- Task and intended clinical role
- Standalone, reader, workflow, bench, retrospective, or prospective design
- Number of patients, studies, images, lesions, readers, and sites
- Reference standard and adjudication method
- Primary endpoint, threshold, confidence interval, and subgroup reporting
Read performance in the context of intended use
FDA notes that different AI-enabled medical-device applications can require different performance metrics. Classification, estimation, segmentation, detection, localization, and time-to-event tasks do not share one universal measure.
The comparison should therefore begin with intended use and workflow role. A strong metric on a different task, population, modality, or deployment setting does not establish equivalence or real-world performance for the device being researched.
Track what is disclosed and what is absent
Public 510(k) summaries vary in detail. Record a missing site count, subgroup result, or confidence interval as not stated rather than zero. Constat keeps extracted fields tied to source quotes so a reviewer can distinguish documented evidence from an absent disclosure.
For changeable AI-enabled functions, also check whether the public record discusses a predetermined change control plan, monitoring, or limits on planned modifications. These fields answer a different question from baseline validation and should remain separate.
Questions researchers ask
Can accuracy be compared directly across AI medical devices?
Only when the task, population, analysis unit, reference standard, threshold, and study design are sufficiently comparable. Otherwise a direct ranking is misleading.
What does not stated mean in a validation summary?
It means the reviewed public source did not disclose the field. It should not be interpreted as zero, not performed, or not required.
Does validation evidence prove current real-world performance?
No. Premarket evidence describes the reviewed study conditions. Postmarket performance can change with sites, populations, workflows, inputs, and later device modifications.